Lilian Ferrari

Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial.

A. Sette, D. Weiskopf, J. Kalil, 2020, The Lancet. Infectious diseases.

Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine

D. Burton, D. Watkins, R. Desrosiers, 2017, Journal of Virology.

Humoral and cellular immune responses to CoronaVac up to one year after vaccination

A. Sette, D. Weiskopf, A. Grifoni, 2022, Frontiers in Immunology.

Humoral and cellular immune responses to CoronaVac assessed up to one year after vaccination

A. Sette, D. Weiskopf, A. Grifoni, 2022, medRxiv.

Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naïve and DENV-Exposed Individuals in a Brazilian Cohort

D. Watkins, D. Magnani, Michael J. Ricciardi, 2022, Frontiers in Immunology.